Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11).

Breast cancer research : BCR - 9 Apr 2026

Shin Seon-Hi, Ahn Sung Gwe, Ryu Jai Min, Lee Sae Byul, Park Hyung Seok, Lee Eun-Shin, Lee Janghee, Kang Byeongju, Kim Sanghwa, Kim Eun Young, Kang Young-Joon, Min Sun Young, Lee Moohyun, Kim Se-Kang, Kim Hong-Kyu, Cha Chihwan David

Abstract excerpt

BACKGROUND: The cumulative risk of contralateral breast cancer (CBC) in BRCA1/2 carriers is remarkably higher than in non-carriers. This study aimed to investigate the clinicopathological predictors associated with the risk of metachronous CBC among breast cancer patients with BRCA1/2 mutations using correspondence analysis. METHODS: This retrospective study included patients who underwent BRCA testing between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Neoplasms, Second Primary

Share to Prognosis

Share to Republic of Korea

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 41957809
DOI: 10.1186/s13058-026-02273-0
PMCID: PMC13181999

Genes

BRCA1
BRCA2
BSG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Contributing factors of contralateral breast cancer in patients with BRCA mutation (ON-BRCA II study, KoREa-BSG 11).PMID 41957809Read ↗

Impact of BRCA Mutation on the Survival and Risk of Contralateral Breast Cancer in Asian Breast Cancer PatientsSemantic proximity Read ↗

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.Semantic proximity Read ↗

BRCA-CRisk: A Contralateral Breast Cancer Risk Prediction Model for BRCA Carriers.Semantic proximity Read ↗

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Triple negative status and BRCA mutations in contralateral breast cancer: a population-based study.Semantic proximity Read ↗

Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.Semantic proximity Read ↗

Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation.Semantic proximity Read ↗

Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.Semantic proximity Read ↗

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.Semantic proximity Read ↗

Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysisSemantic proximity Read ↗

Incidence of contralateral and ipsilateral breast cancers and prognosis in BRCA1/2 pathogenic variant carriers based on the Japanese HBOC Consortium registration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.